SCHEDULE: Sarroff Fund Boosts PetVivo Stake to 39.6% via Private Placement

A.L. Sarroff Fund, LLC and its principals increased their beneficial ownership in PetVivo Holdings, Inc. to 39.6% through a new private placement and warrant agreement.

Summary

• Reporting Persons (A.L. Sarroff Fund, LLC, Alan Sarroff, and Eileen Sarroff) beneficially own an aggregate of 16,433,204 shares of PetVivo Holdings, Inc. common stock, representing approximately 39.6% of the outstanding shares.
• This ownership percentage is calculated based on 35,212,419 shares of common stock outstanding as of March 13, 2026, and assumes the exercise of warrants to purchase 6,255,008 shares.
• On March 13, 2026, the Reporting Persons entered into a Subscription Agreement and Investment Letter to purchase 1,250,000 units from PetVivo Holdings, Inc. in a private placement for $0.80 per unit.
• Each unit purchased consists of one share of common stock and one warrant, with each warrant exercisable for one share of common stock at $1.10.
• The Reporting Persons also have an option, until June 15, 2026, to purchase up to an additional 1,500,000 units from the Issuer at a price of $0.80 per unit.
• The investment is for general investment purposes, and the Reporting Persons intend to continuously review their position and may adjust it in the future through various transactions.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant insider increasing their stake and providing capital through a private placement often signals confidence, despite the discounted unit price.

Positives

• Significant insider investment demonstrates confidence in PetVivo Holdings, Inc.'s future prospects, with the Reporting Persons now holding 39.6% beneficial ownership.
• The private placement provides capital to the Issuer at $0.80 per unit, potentially strengthening its financial position.
• The option for the Reporting Persons to purchase up to an additional 1,500,000 units indicates potential for further capital injection and increased insider commitment.

Negatives

• The private placement price of $0.80 per unit is below the warrant exercise price of $1.10, which could suggest a discount to market value or a need for capital.
• The substantial ownership percentage (39.6%) by a single group could raise concerns about control and influence over corporate decisions and potential for future strategic shifts.

Risks

• The Reporting Persons may increase or decrease their position in the Issuer through open market or private transactions, including derivatives, which could impact share price volatility.
• Future actions by the Reporting Persons, including potential changes in control, mergers, or strategic direction, are not ruled out and could be formulated at any time.
• The exercise of warrants, both existing and those acquired in the private placement, could lead to dilution for existing shareholders.

Future Outlook

The Reporting Persons intend to continuously review their investment in PetVivo Holdings, Inc. and may adjust their position by purchasing or selling securities, including derivatives, based on various factors such as the Issuer's financial position, strategic direction, market conditions, and other investment opportunities. They also reserve the right to formulate plans or proposals related to the Issuer's corporate structure or control in the future.

Industry Context

StockSavvy.ai notes that significant insider accumulation, especially through private placements, can signal strong conviction in a company's long-term prospects, particularly in the biotechnology or animal health sector where PetVivo operates. Such moves often precede strategic shifts or significant product developments, though the filing itself does not detail these.

Comparison to Industry Standards

• This filing primarily details an insider's increased stake and a private placement, rather than operational results. Therefore, direct comparisons to industry-standard operational benchmarks (e.g., revenue growth, profit margins) are not applicable.
• StockSavvy.ai observes that a 39.6% beneficial ownership by a single group is a substantial stake, often seen in smaller, growth-oriented companies or those undergoing significant strategic transitions, where a major investor can exert considerable influence. For example, similar high insider ownership percentages are sometimes seen in early-stage biotech firms like those backed by dedicated venture funds or family offices, where the investor takes a very active role.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of new shares and warrants, but also a vote of confidence from a major investor. The significant ownership by the Sarroff group could influence future corporate decisions.
• Company (PetVivo Holdings, Inc.): Receives capital from the private placement, which can be used for operations or strategic initiatives.

Next Steps

• Reporting Persons will continue to review their investment in PetVivo Holdings, Inc.
• Reporting Persons may exercise their option to purchase up to 1,500,000 additional units by June 15, 2026.
• Reporting Persons may increase or decrease their position in the Issuer through various transactions.
• Reporting Persons may, at any time, formulate plans or proposals regarding the Issuer's corporate structure or control.

Key Dates

Recommendation

The significant increase in beneficial ownership by a major insider group, coupled with a capital injection through a private placement, suggests a strong vote of confidence in PetVivo Holdings, Inc.'s future. However, the discounted price of the units in the private placement ($0.80) compared to the warrant exercise price ($1.10) and the potential for future dilution from warrant exercises or additional unit purchases warrant a cautious approach. While the insider commitment is positive, the implications of such a large stake on corporate control and the potential for future market actions by the Reporting Persons suggest a 'hold' recommendation until further strategic clarity or operational performance is demonstrated.

Keywords

PetVivo Holdings, PVHO, Schedule 13D, Insider Ownership, Private Placement, Warrants, Equity Investment, Beneficial Ownership, Capital Raise